BR112013002030B1 - hidroxiapatita intrinsecamente magnética - Google Patents

hidroxiapatita intrinsecamente magnética Download PDF

Info

Publication number
BR112013002030B1
BR112013002030B1 BR112013002030A BR112013002030A BR112013002030B1 BR 112013002030 B1 BR112013002030 B1 BR 112013002030B1 BR 112013002030 A BR112013002030 A BR 112013002030A BR 112013002030 A BR112013002030 A BR 112013002030A BR 112013002030 B1 BR112013002030 B1 BR 112013002030B1
Authority
BR
Brazil
Prior art keywords
hydroxyapatite
magnetic
ions
intrinsically
drugs
Prior art date
Application number
BR112013002030A
Other languages
English (en)
Other versions
BR112013002030A2 (pt
Inventor
Tampieri Anna
Pressato Daniele
Landi Elena
Rivas Rey Jose
Banobre Lopez Manuel
Marcacci Maurilio
Sandri Monica
Original Assignee
Consiglio Nazionale Ricerche
Fin Ceram Faensa S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche, Fin Ceram Faensa S P A filed Critical Consiglio Nazionale Ricerche
Publication of BR112013002030A2 publication Critical patent/BR112013002030A2/pt
Publication of BR112013002030B1 publication Critical patent/BR112013002030B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
    • C01B25/322—Preparation by neutralisation of orthophosphoric acid
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/45—Phosphates containing plural metal, or metal and ammonium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/62—Submicrometer sized, i.e. from 0.1-1 micrometer
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/60—Optical properties, e.g. expressed in CIELAB-values
    • C01P2006/62—L* (lightness axis)
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/60—Optical properties, e.g. expressed in CIELAB-values
    • C01P2006/64—Optical properties, e.g. expressed in CIELAB-values b* (yellow-blue axis)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Compositions Of Oxide Ceramics (AREA)

Abstract

hidroxiapatita intrisecamente magnética. a presente invenção refere-se à hidroxiapatita dopada com íons fe2+e íons fe3+ que substituem parcialmente os íons de cálcio na treliça de cristal. a hidroxiapatita é caracterizada por um magnetismo intríseco de 0,05 8emu/g, medido aplicando-se um campo magnético de 34 oe, devido à presença de nanodomínios magnéticos na treliça de cristal de ha, dada a quantidade limitada de fases magnéticas secundárias presentes, menor do que aproximadamente 3% em volume. a hidroxiapatita intrinsecamente magnética pode ser carregada com substâncias biológicas selecioanadas no grupo que consiste de proteínas, genes, células-tronco, fatores de crescimento, fatores de vascularização, substâncias ativas e fármacos, sob o controle de um campo magnético externo, como um carregador e agente de liberação para substâncias biológicas ou fármacos, como um agente de contraste em diagnóstico ou para regeneração óssea ou de osteocartilagem.
BR112013002030A 2010-07-29 2011-07-28 hidroxiapatita intrinsecamente magnética BR112013002030B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A001420A IT1401487B1 (it) 2010-07-29 2010-07-29 Idrossiapatite intrinsecamente magnetica
PCT/IB2011/053362 WO2012014172A1 (en) 2010-07-29 2011-07-28 Intrinsically magnetic hydroxyapatite

Publications (2)

Publication Number Publication Date
BR112013002030A2 BR112013002030A2 (pt) 2017-09-19
BR112013002030B1 true BR112013002030B1 (pt) 2020-04-28

Family

ID=43629403

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013002030A BR112013002030B1 (pt) 2010-07-29 2011-07-28 hidroxiapatita intrinsecamente magnética

Country Status (17)

Country Link
US (1) US9327027B2 (pt)
EP (1) EP2598437B1 (pt)
JP (1) JP5822927B2 (pt)
KR (1) KR101854380B1 (pt)
CN (1) CN103038161B (pt)
AU (1) AU2011284364B2 (pt)
BR (1) BR112013002030B1 (pt)
CA (1) CA2806680C (pt)
DK (1) DK2598437T3 (pt)
ES (1) ES2630169T3 (pt)
IL (1) IL224432A (pt)
IT (1) IT1401487B1 (pt)
MX (1) MX349464B (pt)
NZ (1) NZ607003A (pt)
SG (1) SG188186A1 (pt)
WO (1) WO2012014172A1 (pt)
ZA (1) ZA201301272B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011056815A1 (de) * 2011-12-21 2013-08-01 Chemische Fabrik Budenheim Kg Nährstoffzusammensetzung für biologische Systeme
US9353137B2 (en) * 2014-02-07 2016-05-31 Ghassem Amoabediny Method for separation and purification of phosphatidylcholine employing magnetic nanoparticles and compositions so produced
WO2015193836A1 (en) 2014-06-19 2015-12-23 Consiglio Nazionale Delle Ricerche (Cnr) Injectable apatitic cement ionically multi-substituted for regenerative vertebroplasty and kyphoplasty
EP3164106B1 (en) * 2014-07-02 2020-11-11 Universidade Católica Portuguesa Uv-filters, method of producing the same and their use in compositions, in particular sunscreens
US10960192B2 (en) * 2014-07-08 2021-03-30 University Of Maryland, Baltimore Compositions and delivery methods for treating dental infections, inflammation, sensitivity, and for use in dental restorations
RU2607743C1 (ru) * 2015-09-22 2017-01-10 Федеральное государственное бюджетное учреждение науки Институт металлургии и материаловедения им. А.А. Байкова Российской академии наук (ИМЕТ РАН) Способ получения катионзамещенного трикальцийфосфата
WO2017096342A1 (en) * 2015-12-03 2017-06-08 Amrita Vishwa Vidyapeetham Radio-wave responsive doped nanoparticles for image-guided therapeutics
ITUA20161416A1 (it) * 2016-03-07 2017-09-07 Consiglio Nazionale Ricerche Filtro solare fisico costituito da idrossiapatite sostituita in una matrice organica
KR101818852B1 (ko) 2016-05-03 2018-01-16 성균관대학교산학협력단 자성의 베타 삼인산칼슘 구형 입자의 제조 방법 및 이에 의해 제작된 자성의 베타 삼인산칼슘 구형 입자
CN105923617B (zh) * 2016-05-11 2018-01-09 中国科学院上海硅酸盐研究所 一种柱状磁性羟基磷灰石纳米材料及其制备方法
CN106430137B (zh) * 2016-09-27 2018-07-13 哈尔滨理工大学 一种球形纳米羟基磷灰石颗粒的制备方法
KR101927196B1 (ko) 2016-10-26 2018-12-11 전남대학교 산학협력단 자기구동 관절연골 재생 시스템
CN106853264A (zh) * 2016-11-10 2017-06-16 南京市口腔医院 超顺磁性纳米纤维膜支架材料、制备方法和应用
IT201700022625A1 (it) * 2017-02-28 2018-08-28 Consiglio Nazionale Ricerche Filtro per lo scambio di calore e umidità per applicazione in campo medicale e procedimento per la sua produzione
WO2019135216A1 (en) 2018-01-02 2019-07-11 Cartiheal (2009) Ltd. Implantation tool and protocol for optimized solid substrates promoting cell and tissue growth
CN111330089B (zh) * 2020-03-04 2021-08-03 西南交通大学 一种用作骨修复的全降解磁修复水凝胶的制备方法
KR20230114474A (ko) 2022-01-25 2023-08-01 부산대학교 산학협력단 철 이온과 스트론튬 이온이 동시 도핑된 베타-제삼인산칼슘의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
US5344640A (en) 1991-10-22 1994-09-06 Mallinckrodt Medical, Inc. Preparation of apatite particles for medical diagnostic imaging
US7485282B2 (en) * 2004-03-26 2009-02-03 Board Of Trustees Of Michigan State University Method for the preparation of metal oxides in nanometric particle form
US9028871B2 (en) * 2006-04-25 2015-05-12 Washington State University Resorbable ceramics with controlled strength loss rates
TWI375567B (en) * 2007-09-19 2012-11-01 Univ Nat Taiwan One kind of nanometer-scaled magnetic hydroxyapatite particle and its manufacturing method
CN101759170B (zh) 2009-12-23 2011-07-06 天津大学 磁性纳米片状羟基磷灰石及其制备方法和应用

Also Published As

Publication number Publication date
RU2013109226A (ru) 2014-09-10
ITMI20101420A1 (it) 2012-01-30
KR101854380B1 (ko) 2018-05-28
IT1401487B1 (it) 2013-07-26
KR20140009968A (ko) 2014-01-23
EP2598437B1 (en) 2017-04-05
MX2013001169A (es) 2013-06-28
DK2598437T3 (en) 2017-07-17
US20130129634A1 (en) 2013-05-23
AU2011284364B2 (en) 2014-01-23
NZ607003A (en) 2014-09-26
CN103038161B (zh) 2016-08-10
AU2011284364A1 (en) 2013-03-07
CA2806680C (en) 2018-09-04
JP5822927B2 (ja) 2015-11-25
BR112013002030A2 (pt) 2017-09-19
JP2013538775A (ja) 2013-10-17
EP2598437A1 (en) 2013-06-05
CN103038161A (zh) 2013-04-10
US9327027B2 (en) 2016-05-03
CA2806680A1 (en) 2012-02-02
SG188186A1 (en) 2013-04-30
ES2630169T3 (es) 2017-08-18
ZA201301272B (en) 2014-04-30
IL224432A (en) 2016-03-31
WO2012014172A1 (en) 2012-02-02
MX349464B (es) 2017-07-31

Similar Documents

Publication Publication Date Title
BR112013002030B1 (pt) hidroxiapatita intrinsecamente magnética
Xu et al. Copper-modified Ti6Al4V alloy fabricated by selective laser melting with pro-angiogenic and anti-inflammatory properties for potential guided bone regeneration applications
BR112015016082A2 (pt) curativo indicador de umidade
BR112013030597A2 (pt) método e aparelho (1) para fabricação de estruturas absorventes com material absorvente
BR112015007061A8 (pt) composto, composição farmacêutica e uso do composto
BR112012015696A2 (pt) composição líquida anídrica antitranspirante/desodorante
Ohnuki et al. Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes
ZA201408612B (en) Composition comprising a biological control agent and a fungicide selected from inhibitors of the mitosis and cell division or compounds having a multi-site action
AR081166A1 (es) Angiogenesis por el uso de celulas madre placentarias
Li et al. Effects of fluoridation of porcine hydroxyapatite on osteoblastic activity of human MG63 cells
BRPI0815052A2 (pt) Diferenciação de células-tronco pluripotentes por meio de uso de células nutrizes humanas
BR112014009790A2 (pt) composto para modulação antisense da expressão de gccr, seu uso e composição
CL2013000773A1 (es) Uso de agentes de control biologico o quimico para controlar insectos y nematodos en cultivos resistentes; procedimiento para tratar semilla de planta que comprende semilla de planta que comprenden uno o mas de los transgenes del grupo ng.
BR112015015714A2 (pt) suspensão e aglomeração de células pluripotentes humanas para diferenciação em célu-las endócrinas pancreáticas
BR112014031874A2 (pt) método para preparar células-tronco em concentração elevada
BR112013001296A2 (pt) composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa
BR112015031977A2 (pt) gel biocompatível, e, kit
MX2015008436A (es) Composiciones para permeabilizar celulas sanguineos fijos y sus usos.
BR112015000547A2 (pt) métodos para tratar tecido; e composição de tecido
BR112012025285A2 (pt) método para aumentar a atividade em células-tronco humanas
EP2483395A4 (en) NUCLEAR RECEPTOR AND MUTANT THEREOF AND USE THEREOF IN THE REPROGRAMMING OF CELLS
BR112014019378A8 (pt) Processo in vitro de avaliação de pelo menos um agente ativo e uso de um processo de avaliação
BR112017003136A2 (pt) métodos de elaboração de composição e composições para uso como produto desodorante e antitranspirante
UA74392U (ru) Способ моделирования острого деструктивного панкреатита на мелких лабораторных животных
Lurier et al. Effects of radical oxygen species and antioxidants on macrophage polarization

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: CONFORME A IN INPI/DIRPA NO 03 DE 30/09/2016, O DEPOSITANTE DEVERA COMPLEMENTAR A RETRIBUICAO RELATIVA AO PEDIDO DE EXAME DO PRESENTE PEDIDO, DE ACORDO COM TABELA VIGENTE, REFERENTE A(S) GUIA(S) DE RECOLHIMENTO 0000221404596580 (PETICAO 800140131832, DE 17/06/2014).

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/07/2011, OBSERVADAS AS CONDICOES LEGAIS.